Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project)

Matthias May(Barmherzige Brüder Klinikum St. Elisabeth in Straubing), Sabine Brookman‐May(Ludwig-Maximilians-Universität München), Tobias Klatte(Helios Hospital Bad Saarow), Raphaela Waidelich(Ludwig-Maximilians-Universität München), Hendrik Borgmann(Goethe University Frankfurt), Paolo Dell’Oglio, Nina Huck(Heidelberg University), C. Surcel(Institutul Clinic Fundeni), Umberto Capitanio(Vita-Salute San Raffaele University), Luca Cindolo, Stefan Zastrow(University Hospital Carl Gustav Carus), Nina Wagener(Asklepios Klinik Altona), Richard Zigeuner(European Association of Urology), Manfred P. Wirth(University Hospital Carl Gustav Carus), Christian G. Stief(LMU Klinikum), Mireía Musquera(Surgical Specialties (Canada)), Thorsten Ecke(Helios Hospital Bad Saarow), Ingmar Wolff(Universitätsmedizin Greifswald), Shahrokh F. Shariat(Universitätszahnklinik Wien), Daniel Vergho(University of Würzburg), Georg C. Hutterer(Medical University of Graz), Axel Haferkamp(Goethe University Frankfurt), Edwin Herrmann(St. Jude Children's Research Hospital), Laura Krabbe, K. Kalusová(Charles University), Anna Scavuzzo(Instituto Nacional de Cancerología), Cristian Mirvald(Institutul Clinic Fundeni), Sascha Pahernik(Heidelberg University)
Scandinavian Journal of Urology
April 12, 2017
Cited by 5


Related Papers